← All Nasus Pharma LTD filings

Nasus Pharma LTD Schedule 13G passive stakes

Filed when an investor crosses five percent without intending to seek control — the passive counterpart to a 13D.

AMEX
NSRX
Nasus Pharma LTD
SCHEDULE: Balyasny Asset Management Reports 9.99% Stake in Nasus Pharma
Balyasny Asset Management L.P. and affiliated entities have disclosed beneficial ownership of 9.99% of Nasus Pharma Ltd.'s common stock.
AMEX
NSRX
Nasus Pharma LTD
SCHEDULE: Balyasny Asset Management Discloses Nasus Pharma Stake
Balyasny Asset Management L.P. and affiliated entities have reported beneficial ownership of 9.99% of Nasus Pharma Ltd.'s common stock.
AMEX
NSRX
Nasus Pharma LTD
SCHEDULE: Funicular Funds, Cable Car Capital Acquire Nasus Pharma Stake
Funicular Funds, LP and Cable Car Capital, LP, along with Jacob Ma-Weaver, have collectively acquired a 5.2% stake in Nasus Pharma Ltd.
AMEX
NSRX
Nasus Pharma LTD
SCHEDULE: Dr. Ronnie Hershman Boosts Nasus Pharma Stake to 15.3%
Dr. Ronnie Hershman and Hershman Holdings LLC reported a combined beneficial ownership of 15.3% in Nasus Pharma Ltd. as of September 30, 2025.
AMEX
NSRX
Nasus Pharma LTD
SCHEDULE: Dr. Dalia Megiddo Boosts Stake in Nasus Pharma to 20.9%
Dr. Dalia Megiddo has reported beneficial ownership of 20.9% of Nasus Pharma Ltd.'s ordinary shares as of September 30, 2025.
AMEX
NSRX
Nasus Pharma LTD
SCHEDULE: Udi Gilboa Reports 21.1% Stake in Nasus Pharma
Udi Gilboa has reported beneficial ownership of 21.1% of Nasus Pharma Ltd.'s ordinary shares as of September 30, 2025.
AMEX
NSRX
Nasus Pharma LTD
SCHEDULE: Capital Point Discloses 6.35% Stake in Nasus Pharma
Capital Point Ltd. has disclosed a passive beneficial ownership of 6.35% of Nasus Pharma Ltd.'s ordinary shares.